These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30905325)

  • 1. Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic Meningitis.
    Pappa E; Conforti R; Hoang-Xuan K; Alentorn A
    Can J Neurol Sci; 2019 May; 46(3):358-359. PubMed ID: 30905325
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
    Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
    Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: A metanalysis with meta-regression.
    Zagouri F; Zoumpourlis P; Le Rhun E; Bartsch R; Zografos E; Apostolidou K; Dimopoulos MA; Preusser M
    Cancer Treat Rev; 2020 Aug; 88():102046. PubMed ID: 32599393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.
    Bonneau C; Paintaud G; Trédan O; Dubot C; Desvignes C; Dieras V; Taillibert S; Tresca P; Turbiez I; Li J; Passot C; Mefti F; Mouret-Fourme E; Le Rhun E; Gutierrez M
    Eur J Cancer; 2018 May; 95():75-84. PubMed ID: 29635147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
    Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
    Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
    Salgia S; Fleming GF; Lukas RV
    J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration.
    Le Tilly O; Azzopardi N; Bonneau C; Desvignes C; Oberkampf F; Ezzalfani M; Ternant D; Turbiez I; Gutierrez M; Paintaud G
    Clin Pharmacol Ther; 2021 Jul; 110(1):210-219. PubMed ID: 33547646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer: Case report.
    García FJV; Carrión NP; de la Cruz-Merino L
    Medicine (Baltimore); 2020 Jan; 99(1):e18298. PubMed ID: 31895768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
    Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
    J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.
    Oliveira M; Braga S; Passos-Coelho JL; Fonseca R; Oliveira J
    Breast Cancer Res Treat; 2011 Jun; 127(3):841-4. PubMed ID: 21369716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
    Martens J; Venuturumilli P; Corbets L; Bestul D
    Acta Oncol; 2013 Jan; 52(1):175-8. PubMed ID: 22655969
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis.
    Zagouri F; Sergentanis TN; Bartsch R; Berghoff AS; Chrysikos D; de Azambuja E; Dimopoulos MA; Preusser M
    Breast Cancer Res Treat; 2013 May; 139(1):13-22. PubMed ID: 23588955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
    Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
    Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab biosimilar shows potential for breast cancer.
    Baker H
    Lancet Oncol; 2017 Jan; 18(1):e4. PubMed ID: 27956154
    [No Abstract]   [Full Text] [Related]  

  • 15. Which drug would be more effective in treating patients with leptomeningeal metastases from breast cancer: intrathecal thiotepa or methotrexate?
    Altundag K
    Med Oncol; 2024 Jun; 41(8):189. PubMed ID: 38951295
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer.
    Bousquet G; Darrouzain F; de Bazelaire C; Ternant D; Barranger E; Winterman S; Madelaine-Chambin I; Thiebaut JB; Polivka M; Paintaud G; Culine S; Janin A
    J Clin Oncol; 2016 Jun; 34(16):e151-5. PubMed ID: 25547506
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
    Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
    Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosis.
    Perissinotti AJ; Reeves DJ
    Ann Pharmacother; 2010 Oct; 44(10):1633-40. PubMed ID: 20807868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
    Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.
    Beauchesne P
    Lancet Oncol; 2010 Sep; 11(9):871-9. PubMed ID: 20598636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.